Purushottam Lamichhane

Author

University of Miami

Also Known As

Purushottam Lamichhane

124

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Miami Sylvester Comprehensive Cancer Center Mayo Clinic in Florida Mayo Clinic Vanderbilt University

About

Purushottam Lamichhane is an author at University of Miami specializing in medicine, tumor microenvironment, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	403
2	Cell Biology	3	3	403
3	Immunology	3	3	403
4	Autoimmunity	1	1	154
5	Cell Signaling	1	1	100

Purushottam Lamichhane

Publications

852

Citations

H-Index

Page 1

	Year	Citations
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, Cancer Research	2017	158
Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody Lavakumar Karyampudi, Purushottam Lamichhane, Adam D. Scheid, Cancer Research Regressing TumorsImmunologyImmune RegulationCd4 T Cell ResponsesImmunotherapy	2014	154
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer Jashodeep Datta, Xizi Dai, Anna Bianchi, Gastroenterology Lineage PlasticityPancreatic CancerOvercome Immunotherapy ResistanceMedicineStem Cells	2022	149
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer Tulasigeri M. Totiger, Supriya Srinivasan, Venkatakrishna R. Jala, Molecular Cancer Therapeutics	2018	116
PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB Lavakumar Karyampudi, Purushottam Lamichhane, James Krempski, Cancer Research ImmunologyImmune RegulationImmunologic MechanismCd4 T Cell ResponsesInnate Immunity	2015	100
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer Nagaraj S. Nagathihalli, Jason Castellanos, Purushottam Lamichhane, Cancer Research	2018	85
Tobacco Carcinogen–Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer Supriya Srinivasan, Tulasigeri M. Totiger, Chanjuan Shi, Cancer Research	2018	44
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer Siddharth Mehra, Vanessa T. Garrido, Austin R. Dosch, Cancer Research Communications	2023	23
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade Yan Luo, Barath Shreeder, James W. Jenkins, Journal for ImmunoTherapy of Cancer	2023	23

Page 1